With almost 25 years’ experience in biopharma, Mrs. Coulomb has held a variety of roles in the areas of strategy, commercialization, marketing, sales, market research, and market access in large, medium and small biopharma companies. She has worked and/or consulted for Merck, Pfizer, Amgen, Genentech, Biogen, Gilead, and Onyx, among others. She has worked across several therapeutic areas including oncology, hematology, rare diseases, cardio-metabolic, autoimmune diseases, and biosimilars.

As Divisional Vice-President and General Manager for Biogen, she managed a $1.5B Multiple Sclerosis Business in the United States. Previously, as Executive Director at Amgen, she had led a 150-people team to support the launch of Repatha in the United States, served as the Commercial Operations lead for the Intercontinental division, led the Oncology Marketing team, and advised on the acquisition of clinical stage compounds, divestitures and due diligence of assets.

In 2020 she co-authored the Global Guide to Compassionate Use programs.

A native of Argentina, Connie received degrees in Business Administration and Accounting from the University of Buenos Aires, graduating with honors as Magna Cum Laude. She later completed her MBA at Stanford University.